Atlas Invest | $25,000,000 | (Jan 22, 2026)
AiStrike | $7,000,000 | (Jan 22, 2026)
Zarminali Pediatrics | $110,000,000 | (Jan 22, 2026)
Boisson
United States
- Brooklyn, New York
- 28/09/2023
- Unknown
- $5,000,000
Quenching a curious thirst to balance mind and body, Boisson was born out of a love of mixology and a shared necessity of well-being. Our vision is to progress the act of drinking, making it more positive and inclusive.
We don't carry every brand; instead, our team is passionate about curating only the highest quality options out there. Our alternatives to wine, beer, spirits, apéritifs, barware, and more, provide sophisticated sips to those looking for alternatives to alcohol, no matter their reasons why.
With five locations in NYC, an upcoming launch in LA, further US expansion, and a 24/7 online shop, our offerings are available nationwide.
We don't judge. We don't preach. We celebrate The Glass Half Full.
- Industry Retail
- Website https://boisson.co/
- LinkedIn https://www.linkedin.com/company/boissonsips/about/
Related People
Sheetal AiyerFounder
United States -
Houston, Texas,
I am a dynamic business executive with a diverse background and a passion for startups and emerging business growth. I have a broad skillset across operations, strategy, management, marketing, litigation, risk mitigation, and business development. Moreover, I have in-depth experience in transactions, corporate finance and contracting functions in addition to exceptional team leadership capabilities to drive core revenue growth. I have proven excellence driving all aspects of a business as an entrepreneur, investor, leader, manager, strategist, general/in-house counsel, and versatile executive.
One to One Health | $12,000,000 | (Jan 22, 2026)
AnswersNow | $40,000,000 | (Jan 22, 2026)
Claim Health | $4,400,000 | (Jan 22, 2026)
Upscale AI(US) | $200,000,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)
furl | $10,000,000 | (Jan 22, 2026)
humans& | $480,000,000 | (Jan 22, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)